19 completed, 14 unknown, 2 recruiting, 1 not yet recruiting. 36 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 36 | Completed 19, Unknown 14, Recruiting 2, Not yet recruiting 1 |
Follow Adverse Effect: new trials by email Literature Review of Adverse Effect trials Research Report on Adverse Effect
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility and Safety of Sciatic Nerve Paraneural Sheath Block Using a Mid-Femoral Lateral Approach Ultrasound-guided lateral mid-femoral sciatic nerve block, Ultrasound-guided popliteal sciatic nerve block - Adverse Effect, Feasibility Study | Not applicable | Not yet recruiting | General Hospital of Ningxia Medical University | 200 | 2026-01-01 | 2026-01-26 |
| ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment in Preeclamptic Patients Norepinephrine, Phenylephrine - Adverse Effect | Not applicable | Unknown | General Hospital of Ningxia Medical University | 80 | 2025-07-01 | 2023-12-06 |
| 90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients Alpha-Agonist, α-adrenergic receptor agonist - Adverse Effect | Not applicable | Unknown | General Hospital of Ningxia Medical University | 80 | 2025-07-01 | 2023-11-30 |
| Addressing Unintentional Leakage When Using Nasal CPAP - Study A CPAP (fixed mode), APAP (automatic mode) - Continuous Positive Airway Pressure, Adverse Effect | Not applicable | Recruiting | University of Sao Paulo General Hospital | 100 | 2025-04-30 | 2025-04-30 |
| Addressing Unintentional Leakage When Using Nasal CPAP - Study B Oronasal CPAP, Nasal CPAP plus Chinstrap - Continuous Positive Airway Pressure, Adverse Effect | Not applicable | Recruiting | University of Sao Paulo General Hospital | 50 | 2025-04-30 | 2025-04-30 |
| ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment Norepinephrine, Phenylephrine - Adverse Effect | Not applicable | Unknown | General Hospital of Ningxia Medical University | 80 | 2025-04-01 | 2023-12-06 |
| 90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment Alpha-Agonist, α-adrenergic receptor agonist - Adverse Effect | Not applicable | Unknown | General Hospital of Ningxia Medical University | 80 | 2025-04-01 | 2023-11-30 |
| ED90 of Norepinephrine and Phenylephrine Infusions Under Intensive Treatment Norepinephrine, Phenylephrine - Adverse Effect | Not applicable | Completed | General Hospital of Ningxia Medical University | 60 | 2025-01-01 | 2025-05-25 |
| 90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients Alpha-Agonist, α-adrenergic receptor agonist - Adverse Effect | Not applicable | Unknown | General Hospital of Ningxia Medical University | 80 | 2025-01-01 | 2023-11-30 |
| 90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment Alpha-Agonist, α-adrenergic receptor agonist - Adverse Effect | Not applicable | Unknown | General Hospital of Ningxia Medical University | 80 | 2025-01-01 | 2023-11-30 |
| ED90 of Norepinephrine and Phenylephrine Infusions in Preeclamptic Patients Norepinephrine, Phenylephrine - Adverse Effect | Not applicable | Completed | General Hospital of Ningxia Medical University | 60 | 2024-10-03 | 2025-10-06 |
| Intensive Versus Standard Treatment for Hypotension on Maternal Hemodynamics in Preeclamptic Patients Alpha-Agonist, α-adrenergic receptor agonist - Adverse Effect | Not applicable | Unknown | General Hospital of Ningxia Medical University | 160 | 2024-07-01 | 2023-11-30 |
| 6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension Hydroxyethyl starch 130/0.4 - Adverse Effect | Not applicable | Unknown | General Hospital of Ningxia Medical University | 40 | 2024-02-01 | 2024-02-02 |
| Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension in Preeclamptic Patients Alpha-Agonist, α-adrenergic receptor agonist - Adverse Effect | Not applicable | Completed | General Hospital of Ningxia Medical University | 390 | 2023-12-05 | 2026-04-30 |
| Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine Hydroxyethyl starch coload - 0 ml/kg, Hydroxyethyl starch coload - 5 ml/kg, Hydroxyethyl starch coload - 10 ml/kg - Adverse Effect | Not applicable | Completed | General Hospital of Ningxia Medical University | 90 | 2023-10-20 | 2024-02-02 |
| Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia Normal saline, Phenylephrine - Adverse Effect | Not applicable | Unknown | General Hospital of Ningxia Medical University | 95 | 2023-10-01 | 2021-11-29 |
| Ondansetron for Postspinal Anesthesia Hypotension normal saline, Ondansetron 4 mg, Ondansetron 8 mg - Adverse Effect | Not applicable | Completed | General Hospital of Ningxia Medical University | 120 | 2023-06-18 | 2023-11-02 |
| Different Crystalloid Coload Volumes on the 90% ED of Norepinephrine Crystalloid - 0 ml/kg, Crystalloid - 5 ml/kg, Crystalloid - 10 ml/kg - Adverse Effect | Not applicable | Completed | General Hospital of Ningxia Medical University | 90 | 2023-03-21 | 2023-06-22 |
| Physiological and Appetitive Effects of CBD Supplementation Cannabidiol (CBD) supplementation, Placebo supplementation - Appetitive Behavior, Adverse Effect | Not applicable | Unknown | Loughborough University | 30 | 2023-01-20 | 2023-03-17 |
| Comparison of Hydroxyethyl Starch and Crystalloid Coload Combined With Norepinephrine Infusion for Hypotension Hydroxyethyl starch, Crystalloid - Adverse Effect | Not applicable | Completed | General Hospital of Ningxia Medical University | 80 | 2023-01-11 | 2023-03-22 |
Showing 20 of 36. Sign in to see all of them.
Hypotension (4) · Pre-Eclampsia (4) · Pain (2) · Pruritus (2) · Sleep Apnea, Obstructive (2) · Appetitive Behavior (1) · Diabetes Mellitus, Type 2 (1) · Insulin Resistance (1) · Marijuana Abuse (1) · Motor Activity (1) · Sickle Cell Trait (1)
Cardiovascular Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Hypertension, Pregnancy-Induced (4) · Pregnancy Complications (4) · Urogenital Diseases (4) · Vascular Diseases (4) · Apnea (2) · Behavior (2) · Dyssomnias (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Respiration Disorders (2) · Respiratory Tract Diseases (2) · Signs and Symptoms (2)
Norepinephrine (13) · Vasoconstrictor Agents (13) · Phenylephrine (9) · Saline Solution (7) · Crystalloid Solutions (4) · Colloids (3) · Hydroxyethyl Starch Derivatives (2) · Population Groups (2) · Aromatherapy (1) · Calcium Gluconate (1) · Cannabidiol (1) · Continuous Positive Airway Pressure (1) · Control Groups (1) · Dexamethasone (1) · Dexmedetomidine (1)
General Hospital of Ningxia Medical University (28) · University of Sao Paulo General Hospital (2) · Formula30A LLC (1) · Loughborough University (1) · Second Affiliated Hospital of Guangzhou Medical University (1) · TC Erciyes University (1) · University of Milan (1) · University of the French West Indies and French Guiana (1)
China (19) · Brazil (2) · Guadeloupe (1) · Italy (1) · Puerto Rico (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
Yi Chen, M.D. (17) · Xinli Ni, Dr. (7) · Pedro Genta (2) · Xiangsheng Xiong, M.D. (2) · Antonio Carrassi, MD (1) · Cory Rice, D.O. (1) · Junwei Zheng (1) · Li Na (1) · Mona Hedreville, Dr (1) · Olivier Hue, PhD (1) · Wangen Li, MD (1) · Xiangzhao Xu, M.D.; Ph. D (1) · Yonghai Zhang (1)
PMID 32933950, PMID 36166132, PMID 38869701, PMID 40248081, PMID 41200476, PMID 42137315